Gedeon Richter Acquires Significant Stake in Granata Bio
May 13, 2025
Gedeon Richter Plc. has acquired a significant equity stake in U.S.-based Granata Bio and will appoint a representative to Granata's board. The companies also signed a binding term sheet to co-develop BEMFOLA for the U.S. market and a royalty purchase agreement for Granata's hMG program, strengthening Richter's U.S. presence and Granata's fertility therapeutics portfolio.
- Buyers
- Gedeon Richter Plc.
- Targets
- Granata Bio
- Industry
- Biotechnology
- Location
- Massachusetts, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Genenta Acquires Majority Stake in Sophia High Tech
April 26, 2026
Industrial Services
Genenta Science has signed definitive agreements to invest €6 million in two tranches to acquire a controlling/majority position in Sophia High Tech. The first tranche provides a 19.9% stake and the second tranche will increase ownership to 51%, making Sophia High Tech a majority-owned subsidiary.
-
GBA Group MedTech Solutions acquires majority stake in Johner Institut
March 10, 2026
Healthcare Services
GBA Group MedTech Solutions acquired a majority stake in Johner Institut GmbH to expand its European platform for medical device services. The deal strengthens GBA’s regulatory and technology capabilities and expands its service portfolio in consulting and training, including AI-enabled RegTech approaches.
-
Granata Bio Acquires Oviva Therapeutics
April 29, 2025
Biotechnology
Granata Bio has acquired Oviva Therapeutics, a women's health biotech developing OVI-586, a first-in-class therapeutic aimed at extending ovarian function and improving reproductive outcomes. The acquisition expands Granata's fertility and women's health pipeline and will advance OVI-586 toward further development for applications including menopause, contraception, and in vitro fertilization (IVF).
-
Danaher Corporation Acquires Genedata AG
August 19, 2024
Software
Danaher Corporation has acquired Genedata AG, a Basel-based provider of software solutions for biopharmaceutical R&D, and will integrate the company into its Life Sciences segment. The acquisition expands Danaher’s R&D workflow capabilities by adding Genedata’s data-driven informatics and automation tools to accelerate drug discovery and development.
-
Boehringer Ingelheim Acquires Nerio Therapeutics
August 6, 2024
Biotechnology
Boehringer Ingelheim agreed to acquire Nerio Therapeutics, a San Diego-based preclinical biotech focused on PTPN2/N1 phosphatase inhibitors for immuno-oncology, for up to $1.3 billion. Nerio was invested/incubated by Viva BioInnovator and backed by a syndicate including Avalon Ventures; the deal is intended to accelerate development of Nerio’s preclinical program as a cornerstone of Boehringer’s immuno-oncology portfolio.
-
Sotera Health Acquires Gibraltar Laboratories
September 1, 2018
Healthcare Services
Sotera Health LLC, a PE-backed global provider of sterilization and laboratory services, has acquired Gibraltar Laboratories, a family-owned contract microbiology and analytical chemistry testing firm based in Fairfield, New Jersey. The acquisition — advised by Capstone Partners — expands Sotera/Nelson Labs' testing capabilities and geographic presence in the pharma and medical device markets.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.